Ryuta Yamazaki

1.4k citations
33 papers · 1.1k indexed · h-index 18
Topics
Inflammatory mediators and NSAID effects (11 papers)Rheumatoid Arthritis Research and Therapies (7 papers)NF-κB Signaling Pathways (6 papers)
Partner nations
JapanUnited States

In The Last Decade

Ryuta Yamazaki

33 papers receiving 1.1k citations

Peers

Ryuta Yamazaki
Comparison fields: 5 of 106
  • Molecular Biology 543
  • Pharmacology 280
  • Food Science 191
  • Oncology 173
  • Genetics 120
Replace Jun‐Jen Liu with:
Jun‐Jen Liu Taiwan
Ana Elisa Caleiro Seixas Azzolini Brazil
Song‐Kyu Park South Korea
Fayaz Malik India
Li-An Yeh United States
Hiromi Shimada Japan
Hong Yong Peh Singapore
Elisabeth Dussaulx France
E Dussaulx France
Ryuta Yamazaki relative to Jun‐Jen Liu Taiwan Jun‐Jen Liu's profile →
Citations per field
00.5×1.5×2.1×
Jun‐Jen Liu · 1×
Citations per year

Countries citing papers authored by Ryuta Yamazaki

Since Specialization
Citations

This map shows the geographic impact of Ryuta Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuta Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuta Yamazaki more than expected).

Fields of papers citing papers by Ryuta Yamazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuta Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuta Yamazaki. The network helps show where Ryuta Yamazaki may publish in the future.

Co-authorship network of co-authors of Ryuta Yamazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuta Yamazaki. A scholar is included among the top collaborators of Ryuta Yamazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuta Yamazaki. Ryuta Yamazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 17
2 7
3 15
4 16
5 44
6 6
7 85
8 40
9 2
10 66
11 31
12 61
13 118
14 25
15 22
16 19
17 181
18 13
19 7
20 101

About Ryuta Yamazaki

Ryuta Yamazaki is a scholar working on Pharmacology, Rheumatology and Cancer Research, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (11 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and NF-κB Signaling Pathways (6 papers). The work is most often cited by research in Pharmacology (280 citations), Food Science (191 citations) and Pharmaceutical Science (50 citations). Ryuta Yamazaki has collaborated with scholars based in Japan and United States. Frequent co-authors include Takeshi Matsuzaki, Teruo Yokokura, Shinichi Kawai, Shusuke Hashimoto, Natsuko Kusunoki, S Hashimoto, Yutaka Mizushima, Ritsuo Aiyama, Tomihisa Koshino and Renzo Okamoto. Their work appears in journals such as FEBS Letters, Journal of Bacteriology and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026